pharma · Post-bariatric hypoglycaemia · Cushing's disease
Recordati Ireland
Recordati Ireland is a pharma organization headquartered in Cork, IE. Primary therapeutic focus areas include Post-bariatric hypoglycaemia, Cushing's disease, Post-Bariatric Hypoglycaemia. NovaPharmaNews links 4 clinical
Cork, IE HQ
2002 Founded
40 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Cork, IE
- Founded
- 2002
- Employees
- 40
- Programs
- 4
- Drugs
- 11
- Patents
- 0
CLCI699C2203
Phase 2 · small molecule · Cushing's disease
CLCI699C2203 for Cushing's disease is a Phase 2 program (small_molecule) at Recordati Ireland with 1 ClinicalTrials.gov record(s).
Internal code CLCI699C2203
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Recordati Ireland
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Cushing's disease
- Status
- active
- Trials
- 1